AQUAVAC IridoV Receives First Market Authorisation in Singapore
date:Sep 06, 2012
ther Asia-Pacific markets as well.

Now in its 12th year, MSD Animal Healths aquaculture RD center in Singapore has made significant contributions to the identification, understanding and management of fish diseases in the region, Chang added. The laboratory has also played a pivotal role in developing the first range of oil-adjuvanted injection vaccines for yellow tail and amberjack in Japan, as well as successfully developing new vaccines for tilapia and marine fish. Working closely with custo
5/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/19 15:56